Blockman, MCohen, KDe Waal, RGray, AKredo, TMaartens, GNel, JParrish, ARees, HReubenson, G2025-01-042025-01-042020-06-25Blockman M, Cohen K, De Waal R, Gray A, et al. Favipiravir for the prevention and management of COVID-19: evidence review of clinical benefits and harm. South African National Department of Health, 2020.http://www.health.gov.za/wp-content/uploads/2020/12/Rapid-Review-of-Favipiravir-for-COVID-19_25June2020.pdfhttps://hdl.handle.net/11288/598018enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/FavipiravirTreatment of COVID-19Antiviral drugClinical guidelinesPharmacokineticsTechnical Report